Valerie M. Nelson
Expertise in
4
conditions

Dr. Valerie M. Nelson

Family Medicine
7400 W Rawson Ave, Ste 100, 
Franklin, WI 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Expertise in
4
conditions
7400 W Rawson Ave, Ste 100, 
Franklin, WI 

Overview

Valerie M. Nelson, MD, is a family medicine doctor with Ascension Wisconsin in Franklin, WI. She provides primary care for minor illness and injuries, preventive health screenings, routine check-ups and vaccinations. Dr. Nelson listens to understand you and your health concerns. She takes the time to get to know you and your family's health history. Then, Dr. Nelson works with you to create a personalized care plan for your long-term health needs.

Dr. Nelson is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Wieacker Wolff Syndrome, Myofibrillar Myopathy, Cytoplasmic Body Myopathy, and Inclusion Body Myopathy 2.

Dr. Nelson is board certified in The American Board Of Family Medicine - Family Medicine. She is actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 11 clinical trials. Dr. Nelson is currently accepting new patients.

Specialties

Family Medicine

Licenses

Family Medicine in OR

Board Certifications

The American Board Of Family Medicine - Family Medicine

Hospital Affiliations

Ascension Columbia St Marys Hospital Milwaukee
Northwestern Lake Forest Hospital
Ascension Se Wisconsin Hospital
Ascension St Francis Hospital
Ascension Columbia St. Mary's Hospital Milwaukee

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Children's Community Health
  • EPO
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Common Ground Healthcare
  • OTHER COMMERCIAL
Common Ground Healthcare Cooperative
  • EPO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Icare Independent Care Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Network Health
  • HMO
Quartz Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 23 Less Insurance Carriers -

Locations

Ascension Medical Group WI - Rawson Avenue - Family Medicine
7400 W Rawson Ave, Ste 100, Franklin, WI 53132

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Phase 2, Single Arm, Multi-center, Open Label Trial Combining Optune With Concurrent Bevacizumab in the Setting of Recurrent or Progressive Meningioma
A Phase 2, Single Arm, Multi-center, Open Label Trial Combining Optune With Concurrent Bevacizumab in the Setting of Recurrent or Progressive Meningioma
Enrollment Status: Recruiting
Publish Date: June 27, 2025
Intervention Type: Procedure, Device, Biological
Study Phase: Phase 2
A Phase II Clinical Trial Evaluating Ibrutinib Maintenance Following Intensive Induction for Patients With Previously Untreated Mantle Cell Lymphoma (MCL)
A Phase II Clinical Trial Evaluating Ibrutinib Maintenance Following Intensive Induction for Patients With Previously Untreated Mantle Cell Lymphoma (MCL)
Enrollment Status: Completed
Publish Date: June 10, 2026
Intervention Type: Drug, Other
Study Drug: Ibrutinib
Study Phase: Phase 2
Phase I/Ib Study of Nivolumab and Veliparib in Patients With Advanced Solid Tumors and Lymphoma With and Without Alterations in Selected DNA Repair Genes
Phase I/Ib Study of Nivolumab and Veliparib in Patients With Advanced Solid Tumors and Lymphoma With and Without Alterations in Selected DNA Repair Genes
Enrollment Status: Completed
Publish Date: June 12, 2024
Intervention Type: Biological, Other, Drug
Study Drugs: Nivolumab, Veliparib
Study Phase: Phase 1
A Phase 0 First-In-Human Study Using NU-0129: A Spherical Nucleic Acid (SNA) Gold Nanoparticle Targeting BCL2L12 in Recurrent Glioblastoma Multiforme or Gliosarcoma Patients
A Phase 0 First-In-Human Study Using NU-0129: A Spherical Nucleic Acid (SNA) Gold Nanoparticle Targeting BCL2L12 in Recurrent Glioblastoma Multiforme or Gliosarcoma Patients
Enrollment Status: Completed
Publish Date: August 26, 2022
Intervention Type: Other, Drug
Study Phase: Early Phase 1
Phase I/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With R-CHOP in a Cohort of Patients With DLBCL/tFL/ High Grade B-NHL
Phase I/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With R-CHOP in a Cohort of Patients With DLBCL/tFL/ High Grade B-NHL
Enrollment Status: Suspended
Publish Date: August 15, 2022
Intervention Type: Other, Drug, Biological
Study Drugs: Cyclophosphamide, Doxorubicin Hydrochloride, Nivolumab, Prednisone, Rituximab, Vincristine Sulfate
Study Phase: Phase 1/Phase 2
A Phase II Study of Pazopanib With Oral Topotecan in Patients With Metastatic and Non-resectable Soft Tissue and Bone Sarcomas
A Phase II Study of Pazopanib With Oral Topotecan in Patients With Metastatic and Non-resectable Soft Tissue and Bone Sarcomas
Enrollment Status: Completed
Publish Date: June 07, 2022
Intervention Type: Drug, Other
Study Drugs: Pazopanib Hydrochloride, Topotecan Hydrochloride
Study Phase: Phase 2
A Single Arm Phase II Study Evaluating the Efficacy and Safety of MEDI4736 in Combination With Tremelimumab in Patients With Metastatic Her2 Negative Breast Cancer
A Single Arm Phase II Study Evaluating the Efficacy and Safety of MEDI4736 in Combination With Tremelimumab in Patients With Metastatic Her2 Negative Breast Cancer
Enrollment Status: Completed
Publish Date: May 17, 2022
Intervention Type: Other, Biological
Study Phase: Phase 2
Parallel Proof of Concept Phase 2 Study of Nivolumab and Metformin Combination Treatment in Advanced Non-small Cell Lung Cancer With and Without Prior Treatment With PD-1/PD-L1 Inhibitors
Parallel Proof of Concept Phase 2 Study of Nivolumab and Metformin Combination Treatment in Advanced Non-small Cell Lung Cancer With and Without Prior Treatment With PD-1/PD-L1 Inhibitors
Enrollment Status: Unknown
Publish Date: October 14, 2020
Intervention Type: Drug, Biological, Other
Study Drugs: Metformin Hydrochloride, Nivolumab
Study Phase: Phase 2
Phase II Study of Pembrolizumab and Capecitabine for Advanced Triple Negative and Hormone-Refractory Breast Cancer
Phase II Study of Pembrolizumab and Capecitabine for Advanced Triple Negative and Hormone-Refractory Breast Cancer
Enrollment Status: Unknown
Publish Date: July 13, 2020
Intervention Type: Other, Drug, Biological
Study Drugs: Capecitabine, Pembrolizumab
Study Phase: Phase 2
A Phase II Single Arm Study of Palbociclib in Patients With Metastatic HER2-positive Breast Cancer With Brain Metastasis
A Phase II Single Arm Study of Palbociclib in Patients With Metastatic HER2-positive Breast Cancer With Brain Metastasis
Enrollment Status: Terminated
Publish Date: April 14, 2020
Intervention Type: Biological, Procedure, Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

12 Total Publications

Nivolumab in combination with R-CHOP for treatment-naïve diffuse large B-cell lymphoma: an evaluation of safety and efficacy.
Nivolumab in combination with R-CHOP for treatment-naïve diffuse large B-cell lymphoma: an evaluation of safety and efficacy.
Journal: Blood advances
Published: February 24, 2025
Similar Doctors
Expertise in
2
conditions
Expertise in
2
conditions

Aurora Medical Group Inc.

3301 W Forest Home Ave, 
Milwaukee, WI 
 (6.1 miles away)
414-649-6732
Languages Spoken:
English
See accepted insurances

Dennis Baumgardner is a primary care provider, practicing in Family Medicine in Milwaukee, Wisconsin. Dr. Baumgardner is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Blastomycosis, Familial Chronic Mucocutaneous Candidiasis, Bronchitis, and Boils.

Expertise in
55
conditions
Dr. Michael J. Hafran
Family Medicine
Expertise in
55
conditions
Dr. Michael J. Hafran
Family Medicine
Before you request

A2cl Aurora Health Center-Menomonee Falls

N84W16889 Menomonee Ave, 
Menomonee Falls, WI 
 (18.4 miles away)
262-251-7500
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Hafran is a primary care provider, practicing in Family Medicine in Menomonee Falls, Wisconsin. Dr. Hafran is highly rated in 55 conditions, according to our data. His clinical expertise encompasses Long Haul COVID, Osteoarthritis, Gastroparesis, and Restless Legs Syndrome. Dr. Hafran is currently accepting new patients.

Expertise in
19
conditions
Dr. Duy-bao P. Dinh
Family Medicine
Expertise in
19
conditions
Dr. Duy-bao P. Dinh
Family Medicine

Amethyst Health Of Brown Deer

7500 W Dean Rd, 
Milwaukee, WI 
 (17.6 miles away)
877-866-7123
Experience:
18+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Duy-bao Dinh is a primary care provider, practicing in Family Medicine in Milwaukee, Wisconsin. He has been practicing medicine for over 18 years. Dr. Dinh is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Peptic Ulcer, Necrosis, Cellulitis, and Jock Itch.

Frequently Asked Questions about Dr. Valerie M. Nelson

How do I make an appointment with Dr. Valerie M. Nelson?

You can book an appointment with Dr. Valerie M. Nelson by calling their office at 414-425-7000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Valerie M. Nelson a top-rated expert for Wieacker Wolff Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Valerie M. Nelson is classified as an Advanced expert for Wieacker Wolff Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Valerie M. Nelson specialize in?

While Dr. Valerie M. Nelson is a Family Medicine, they have specific expertise in Wieacker Wolff Syndrome, Myofibrillar Myopathy, and Cytoplasmic Body Myopathy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Valerie M. Nelson participate in research or clinical trials?

Yes. Dr. Valerie M. Nelson has published 12 articles and abstracts on conditions like Wieacker Wolff Syndrome. You can view a list of Dr. Valerie M. Nelson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Valerie M. Nelson accept my insurance?

Dr. Valerie M. Nelson accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 414-425-7000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nelson's expertise for a condition
ConditionClose
      View All 29 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile